Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

The behavior of alpha-synuclein in neurons.

Fortin DL, Nemani VM, Nakamura K, Edwards RH.

Mov Disord. 2010;25 Suppl 1:S21-6. doi: 10.1002/mds.22722.

PMID:
20187244
[PubMed - indexed for MEDLINE]
2.

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.

Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.

PMID:
19903734
[PubMed - indexed for MEDLINE]
Free Article
3.

Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved.

Ubeda-Bañon I, Saiz-Sanchez D, de la Rosa-Prieto C, Mohedano-Moriano A, Fradejas N, Calvo S, Argandoña-Palacios L, Garcia-Muñozguren S, Martinez-Marcos A.

Mov Disord. 2010 Aug 15;25(11):1701-7. doi: 10.1002/mds.23197.

PMID:
20574962
[PubMed - indexed for MEDLINE]
4.

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.

Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB.

J Neurosci. 2007 Mar 21;27(12):3338-46.

PMID:
17376994
[PubMed - indexed for MEDLINE]
Free Article
5.

Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.

Furukawa K, Matsuzaki-Kobayashi M, Hasegawa T, Kikuchi A, Sugeno N, Itoyama Y, Wang Y, Yao PJ, Bushlin I, Takeda A.

J Neurochem. 2006 May;97(4):1071-7. Epub 2006 Apr 5.

PMID:
16606366
[PubMed - indexed for MEDLINE]
6.

Clues to how alpha-synuclein damages neurons in Parkinson's disease.

Sulzer D.

Mov Disord. 2010;25 Suppl 1:S27-31. doi: 10.1002/mds.22639.

PMID:
20187229
[PubMed - indexed for MEDLINE]
7.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64. Epub 2005 Jul 6.

PMID:
16000336
[PubMed - indexed for MEDLINE]
Free Article
8.

Neural activity controls the synaptic accumulation of alpha-synuclein.

Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, Edwards RH.

J Neurosci. 2005 Nov 23;25(47):10913-21.

PMID:
16306404
[PubMed - indexed for MEDLINE]
Free Article
9.

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK.

J Biol Chem. 2008 Apr 4;283(14):9089-100. doi: 10.1074/jbc.M710012200. Epub 2008 Feb 1.

PMID:
18245082
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Controlling the mass action of alpha-synuclein in Parkinson's disease.

Kim C, Lee SJ.

J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. Review.

PMID:
18691382
[PubMed - indexed for MEDLINE]
11.

Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.

Halliday GM, McCann H.

Exp Neurol. 2008 Jan;209(1):12-21. Epub 2007 Jul 17. Review.

PMID:
17706644
[PubMed - indexed for MEDLINE]
12.

Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations.

McLean PJ, Kawamata H, Ribich S, Hyman BT.

J Biol Chem. 2000 Mar 24;275(12):8812-6.

PMID:
10722726
[PubMed - indexed for MEDLINE]
Free Article
13.

Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, Björklund A.

J Neurosci. 2002 Apr 1;22(7):2780-91.

PMID:
11923443
[PubMed - indexed for MEDLINE]
Free Article
14.

G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.

Liu P, Wang X, Gao N, Zhu H, Dai X, Xu Y, Ma C, Huang L, Liu Y, Qin C.

Brain Res. 2010 Jan 11;1307:134-41. doi: 10.1016/j.brainres.2009.10.036. Epub 2009 Oct 21.

PMID:
19852948
[PubMed - indexed for MEDLINE]
15.

Raised calcium promotes α-synuclein aggregate formation.

Nath S, Goodwin J, Engelborghs Y, Pountney DL.

Mol Cell Neurosci. 2011 Feb;46(2):516-26. doi: 10.1016/j.mcn.2010.12.004. Epub 2010 Dec 9.

PMID:
21145971
[PubMed - indexed for MEDLINE]
16.

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.

Kontopoulos E, Parvin JD, Feany MB.

Hum Mol Genet. 2006 Oct 15;15(20):3012-23. Epub 2006 Sep 7.

PMID:
16959795
[PubMed - indexed for MEDLINE]
Free Article
17.

Alpha-synuclein and Parkinson's disease.

Lücking CB, Brice A.

Cell Mol Life Sci. 2000 Dec;57(13-14):1894-908. Review.

PMID:
11215516
[PubMed - indexed for MEDLINE]
18.

Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.

Stöckl M, Fischer P, Wanker E, Herrmann A.

J Mol Biol. 2008 Feb 1;375(5):1394-404. Epub 2007 Nov 22.

PMID:
18082181
[PubMed - indexed for MEDLINE]
19.

alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.

Sidhu A, Wersinger C, Vernier P.

FEBS Lett. 2004 May 7;565(1-3):1-5. Review.

PMID:
15135042
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk